Low productivity in CNS research can be explained by several motivations: e.g., patient heterogeneity, complexity of neurodegenerative diseases, the relatively low predictive validity of animal models, the relative lack of established clinical biomarker…
RT @ideapharma: Alex is right, *but* look at the absolute horror of this… As I wrote yesterday, making pI/pII easier is the wrong behaviour…
RT @biogerontology: This a very useful under-the-radar low-Altmetric paper on pharmaceutical R&D, which I missed in 2020 and only recently…
RT @biogerontology: This a very useful under-the-radar low-Altmetric paper on pharmaceutical R&D, which I missed in 2020 and only recently…